{"name":"Sorriso Pharmaceuticals, Inc.","slug":"sorriso-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1kNThzU1RrU09sakFCdlJaOXVVZnZhcjg2OXpIajhaMEk4N25DaF95YXo0Tk9ZakdYRl92bnBLcXZmdkZJaG1YZzVCSFVmSFRmdHpybHhTMEdVQTJQZFNDb1dXYzExZw?oc=5","date":"2025-10-30","type":"pipeline","source":"MedPage Today","summary":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC - MedPage Today","headline":"Novel Oral miR-124 Enhancer Improves Remission in Refractory UC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQUUFZWTMybVhaRXB4MFpLMUxPb3RnZ1VQWVVEQ2JiZmFnTllGLTNleV9Ka0ZYM2h0TjdndHk2UWZCSkNIcnhGbkxwNlAzZFY3UUxqTW9LX2VrQ2ZUTFotVGJzaDRtOC1QUjduSlp6bXJDUmRpdW16MlZUZVhUbFdGT1lRMFA1T3ZwcWdfRU9QRkdpYlM1c0toNUlDY2gzdy1ndGU5SU5qQk0za0NFQWJVcmUtREJYMDF1cXAyaktoOHpITHZOR3NVZThnUVVVdkdVNFVJQTU2ZlVYdHdsUkdOYVVidHg3bkVxSG45MVc2d3BfQzdLaGZzSjFuS3dVNWVRQncwREMyN0hxbjlHSkE?oc=5","date":"2025-10-30","type":"pipeline","source":"BioSpace","summary":"Alethio Therapeutics Launches with New CEO and Chair to Advance Two Targeted Medicines for Myeloproliferative Neoplasms (Chronic Blood Cancers) - BioSpace","headline":"Alethio Therapeutics Launches with New CEO and Chair to Advance Two Targeted Medicines for Myeloproliferative Neoplasms ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOcVp3NkRQZ0tYa0k2WGhjVy1VMXRfczVnT01CaXNuanIwbEFzV1huMnFjZGdGVGhZNjJsRC1pQmhfQ1lFdXBtcURnSko0MU9QYklDT3ZieXBGQjFOcVM4N2xlS25JekVyd2lHeE9ZUUVuZmFFOTBhS2Z1TEtLel94TGplRjg4UDhIQ0lkRVR5eVlPOHU5cmxKcVZjRnF0SEZ5ZVh0MVZEQ2s0bjhRbXctNE1vRFhTeENlVzFqeUxTbWFYczlxemVmSDE4LWJKNlI3LTNrT2Ffb1lfNFVaZ2sxbGtkRXRfbXJyajJaNGhlT2Zwal80TXVv?oc=5","date":"2024-12-19","type":"trial","source":"businesswire.com","summary":"Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis - businesswire.com","headline":"Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNMk1QdXJuTE9wc1hRYWs5SDNNWGdjQ0V3RDdvT0xMbndnLV9aNDh6UlRDaTZReTFtMTdLb253VUlqa3YzOTh0VlVhZUtGUEFNdVo0dGhYWG5pcWNuY1JiTFRyLWg1NzJ0M2FfWVdfZnJudlZrMFFoVWU3MUtlRGpPSnBzZkNIWjh3VUZxakRBR1ZIcG8xVUx2R1NJa016UmZnblNGXy1rYWk2Q29oVkwzdjVBYm1NREpZd2ZON3Y3MXVSTko0Tmg3aW1BSXJDekNhN29pazdSZUxpV0VjZ1AxZw?oc=5","date":"2022-01-13","type":"pipeline","source":"prnewswire.com","summary":"Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline - prnewswire.com","headline":"Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}